HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Sub-New Stocks

317.484

-1.962-0.61%

Number of Gainers:13

Number of Losers:34

Number of Flat:12

PE:- -

High:319.886

Open:319.429

Low:313.595

Close:319.447

Volume:104.60M

Turnover:3.56B

Market Cap:752.35B

Float Cap:670.18B

Loading ...

HUTCHMED Sees Positive High Level Results in Lung Cancer Drug Combo Trial

MT Newswires Live

Hutchmed (China) - Announces Positive Results from Sanovo China Phase Trial in Nsclc Patients

THOMSON REUTERS

Hutchmed Announces Sanovo Trial Demonstrated Significant Progression-Free Survival Benefit of Orpathys® Plus Tagrisso® in Treatment-NaÏVe Patients with Met-Overexpressing Egfr-Mutated Lung Cancer in China

THOMSON REUTERS

Zhaoke Ophthalmology (SEHK:6622) Stock Carries A 34.7x P/S Under Heavy Losses

Simply Wall St.

The Fall of a Former Tea Industry Pioneer: From Market Darling to Penny Stock

Revenue Miss: MIXUE Group Fell 11% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models

Simply Wall St.

Here's Why UNQ Holdings (HKG:2177) Has Caught The Eye Of Investors

Simply Wall St.

Medlive Technology (SEHK:2192) Stock Holds Firm As Margin Strength Meets Growth Questions

Simply Wall St.

LING YUE SER GP Reports Interim Results: Net Profit Down 35.3% to RMB 34.3 Million

GLOBAL NEW MAT posts interim loss of RMB134 million, swinging from profit

Yesasia Holdings Says Board Has Resolved not to Declare Any Interim Dividend

YesAsia Holdings Replicates Record High Half-Year Results: Revenue Grows 23.2% to Us$301.51 Million; Net Profit Surges 30.0% to Us$18.30 Million

THOMSON REUTERS

LANDSEA LIFE Reports Mid-Year Results with Net Profit Soaring 230%

Mixue Pauses Expansion Race: Three-Year Overhaul Targets Quality Upgrade and IP-Led Demand

Zhaoke Ophthalmology's Half-Year Results: Net Loss Widens to RMB 123 Million Amid Rising Costs

Ling Yue Services H1 FY26 Net Profit Drops 35.3% to RMB 34.3 Million; Revenue Falls 8% to RMB 295.4 Million

China's Ocumension Therapeutics H1 Revenue Surges on Higher Ophthalmic Product Sales

InnoScience Appoints Wei Yu CFO, Replacing Zhong Shan

Global New Material Swings to FY26 H1 Net Loss of RMB 93.36 Million; Revenue More than Doubled to RMB 2.56 Billion

Property Manager Landsea Green Life's H1 Revenue Falls on Exits from Loss-Making Projects

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/BK1587/news?page=12"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1587","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1587\",,,,,undefined,":{"symbol":"BK1587","market":"HK","secType":"PLATE","nameCN":"Sub-New Stocks","latestPrice":317.4844,"timestamp":1789114133774,"preClose":319.44687,"halted":0,"volume":104597924,"delay":0,"changeRate":-0.006143,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-1.962463,"latestTime":"09-11 16:00:00","open":319.42862,"high":319.88553,"low":313.59467,"amount":3559134410.4,"amplitude":0.019693,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789349400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789090200000,1789099200000],[1789102800000,1789113600000]],"pbRate":1.339379,"peRate":15.260692,"turnoverRate":0.002002,"increases":12,"decrements":36,"flats":10,"marketCap":752353199316,"floatMarketCap":670179486148},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1587\",,,,,undefined,":{"symbol":"BK1587","high":319.88553,"amplitude":0.019693,"preClose":319.44687,"low":313.59467,"pbRate":"1.339379","latestPrice":317.4844,"volume":104597924,"delay":0,"open":319.42862,"prevYearClose":478.5753,"prevWeekClose":332.269,"prevMonthClose":342.657,"prevQuarterClose":326.657,"fiveDayClose":332.269,"twentyDayClose":346.279,"sixtyDayClose":361.102,"secType":"PLATE","market":"HK","turnoverRate":0.002002,"peRate":15.260692,"marketCap":752353199316,"floatMarketCap":670179486148,"timestamp":1789114133774,"nameCN":"Sub-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1587\",,,,undefined,":{"bkCode":"BK1587","up":13,"down":34,"flat":12},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1587\",pageSize:20,pageCount:12,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2663579022","title":"HUTCHMED Sees Positive High Level Results in Lung Cancer Drug Combo Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2663579022","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663579022?lang=en_us&edition=fundamental","pubTime":"2026-08-31 13:39","pubTimestamp":1788154752,"startTime":"0","endTime":"0","summary":"HUTCHMED   announced positive high-level results from its SANOVO China phase  trial in treatment-nave patients with non-small cell lung cancer, according to a Monday Hong Kong bourse filing.ORPATHYS plus TAGRSSO significantly improved progression-free survival versus TAGRSSO alone in both high MET and intention-to-treat patient populations.The combination also showed an encouraging clinical benefit in overall survival in both populations, which was a secondary endpoint of the trial.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1191","BK1587","BK1588","00013"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663028693","title":"Hutchmed (China) - Announces Positive Results from Sanovo China Phase Trial in Nsclc Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2663028693","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663028693?lang=en_us&edition=fundamental","pubTime":"2026-08-31 08:00","pubTimestamp":1788134458,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R00K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","BK1588","00013","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663695028","title":"Hutchmed Announces Sanovo Trial Demonstrated Significant Progression-Free Survival Benefit of Orpathys® Plus Tagrisso® in Treatment-NaÏVe Patients with Met-Overexpressing Egfr-Mutated Lung Cancer in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2663695028","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663695028?lang=en_us&edition=fundamental","pubTime":"2026-08-31 08:00","pubTimestamp":1788134402,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nTUA57F9PY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","00013","BK1588","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663266430","title":"Zhaoke Ophthalmology (SEHK:6622) Stock Carries A 34.7x P/S Under Heavy Losses","url":"https://stock-news.laohu8.com/highlight/detail?id=2663266430","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663266430?lang=en_us&edition=fundamental","pubTime":"2026-08-31 06:36","pubTimestamp":1788129366,"startTime":"0","endTime":"0","summary":"Traders kept Zhaoke Ophthalmology almost flat coming into the H1 2026 report, with the stock up only about 2% over the past week. The calm price action contrasts with a much more charged reality. The company is still posting heavy losses, with H1 basic earnings per share at a loss of ¥0.22 and a net loss of ¥122.6 million.\nThe key issue is valuation. Zhaoke Ophthalmology trades on a P/S multiple of 34.7x, compared with the Hong Kong pharmaceuticals average near 2x. This puts every line of...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6622/zhaoke-ophthalmology-shares/news/zhaoke-ophthalmology-sehk6622-stock-carries-a-347x-ps-under","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6622/zhaoke-ophthalmology-shares/news/zhaoke-ophthalmology-sehk6622-stock-carries-a-347x-ps-under","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1583","BK1587","06622","BK1191","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109313631","title":"The Fall of a Former Tea Industry Pioneer: From Market Darling to Penny Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=1109313631","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109313631?lang=en_us&edition=fundamental","pubTime":"2026-08-30 12:20","pubTimestamp":1788063638,"startTime":"0","endTime":"0","summary":"At a franchisee conference held in southwest China in July 2026, the management of NAYUKI (HK: 02150) spent nearly an hour presenting a new compact store model designed to shrink floor space to as...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02150","BK1616","BK1587","BK1233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663045337","title":"Revenue Miss: MIXUE Group Fell 11% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models","url":"https://stock-news.laohu8.com/highlight/detail?id=2663045337","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663045337?lang=en_us&edition=fundamental","pubTime":"2026-08-30 09:00","pubTimestamp":1788051612,"startTime":"0","endTime":"0","summary":"MIXUE Group ( HKG:2097 ) shareholders are probably feeling a little disappointed, since its shares fell 9.0% to HK$212...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/4214000-choice1-main-header/1585186691957","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4214000-choice1-main-header/1585186691957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/consumer-services/hkg-2097/mixue-group-shares/news/revenue-miss-mixue-group-fell-11-short-of-analyst-revenue-es","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/consumer-services/hkg-2097/mixue-group-shares/news/revenue-miss-mixue-group-fell-11-short-of-analyst-revenue-es","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["02097","BK1616","JOYT","PMDE","VOTE","DECU","BK1587","GXDW","VGFPF","RGLO","FEBU","BK1233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663045364","title":"Here's Why UNQ Holdings (HKG:2177) Has Caught The Eye Of Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2663045364","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663045364?lang=en_us&edition=fundamental","pubTime":"2026-08-30 08:39","pubTimestamp":1788050345,"startTime":"0","endTime":"0","summary":"For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/4422000-choice2-main-header/1585186866479","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4422000-choice2-main-header/1585186866479"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/retail/hkg-2177/unq-holdings-shares/news/heres-why-unq-holdings-hkg2177-has-caught-the-eye-of-investo","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/retail/hkg-2177/unq-holdings-shares/news/heres-why-unq-holdings-hkg2177-has-caught-the-eye-of-investo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1587","BK1142","BK4211","ISBC","EBIT","BK1224","02177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663453650","title":"Medlive Technology (SEHK:2192) Stock Holds Firm As Margin Strength Meets Growth Questions","url":"https://stock-news.laohu8.com/highlight/detail?id=2663453650","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663453650?lang=en_us&edition=fundamental","pubTime":"2026-08-30 08:27","pubTimestamp":1788049647,"startTime":"0","endTime":"0","summary":"Medlive Technology went into this earnings print with a growth story and a valuation that screens cheaper than many Asian healthcare services peers. The stock closed at HK$7.67 on the day of the release after a flat to slightly soft week, even as the latest half year numbers kept profit quality in focus. The headline is simple. Revenue reached ¥315.2m in the first half of 2026 and basic earnings per share came in at ¥0.2187. That keeps Medlive firmly profitable while investors weigh what the...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-2192/medlive-technology-shares/news/medlive-technology-sehk2192-stock-holds-firm-as-margin-stren","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-2192/medlive-technology-shares/news/medlive-technology-sehk2192-stock-holds-firm-as-margin-stren","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1189","LU0049112450.USD","LU1235295612.USD","BK1587","LU1046422090.SGD","02192"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122872312","title":"LING YUE SER GP Reports Interim Results: Net Profit Down 35.3% to RMB 34.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1122872312","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122872312?lang=en_us&edition=fundamental","pubTime":"2026-08-29 00:42","pubTimestamp":1787935336,"startTime":"0","endTime":"0","summary":"LING YUE SER GP (02165) has announced its financial results for the six months ended June 30, 2026, revealing a decline in both revenue and profit during the period.The group recorded revenue of RMB...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1229","BK1587","02165","BK1542","BK1258"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121124875","title":"GLOBAL NEW MAT posts interim loss of RMB134 million, swinging from profit","url":"https://stock-news.laohu8.com/highlight/detail?id=1121124875","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121124875?lang=en_us&edition=fundamental","pubTime":"2026-08-29 00:18","pubTimestamp":1787933925,"startTime":"0","endTime":"0","summary":"GLOBAL NEW MAT (06616) has released its interim results for the six months ended 30 June 2026, reporting a sharp swing into the red.The group achieved revenue of RMB2.558 billion, marking a...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","06616","BK1129","LU0274383008.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663920600","title":"Yesasia Holdings Says Board Has Resolved not to Declare Any Interim Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2663920600","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663920600?lang=en_us&edition=fundamental","pubTime":"2026-08-29 00:07","pubTimestamp":1787933271,"startTime":"0","endTime":"0","summary":"BRIEF-Yesasia Holdings Says Board Has Resolved Not To Declare Any Interim DividendAug 28 (Reuters)-YesAsia Holdings Ltd2209.HK:BOARD HAS RESOLVED NOT TO DECLARE ANY INTERIM DIVIDENDH1 NET INCOME ATTRIBUTABLE USD 18.3 MILLIONH1 REVENUE USD 301.5 MILLIONFurther company coverage:2209.HK","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nFWN44P1XT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02209","BK1142","BK1114","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662609264","title":"YesAsia Holdings Replicates Record High Half-Year Results: Revenue Grows 23.2% to Us$301.51 Million; Net Profit Surges 30.0% to Us$18.30 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662609264","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662609264?lang=en_us&edition=fundamental","pubTime":"2026-08-28 23:45","pubTimestamp":1787931913,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nTUC9MDGPJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02209","BK1587","BK1114","BK1142"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141590752","title":"LANDSEA LIFE Reports Mid-Year Results with Net Profit Soaring 230%","url":"https://stock-news.laohu8.com/highlight/detail?id=1141590752","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141590752?lang=en_us&edition=fundamental","pubTime":"2026-08-28 23:44","pubTimestamp":1787931884,"startTime":"0","endTime":"0","summary":"LANDSEA LIFE (01965) has announced its interim results for the six months ended June 30, 2026, showing a significant jump in profitability despite a slight dip in revenue. The company recorded...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1229","BK1258","01965","BK1542","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120588790","title":"Mixue Pauses Expansion Race: Three-Year Overhaul Targets Quality Upgrade and IP-Led Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=1120588790","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120588790?lang=en_us&edition=fundamental","pubTime":"2026-08-28 22:56","pubTimestamp":1787928980,"startTime":"0","endTime":"0","summary":"After years of rapid expansion, Mixue Bingcheng has deliberately slowed its pace.On August 27, MIXUE GROUP disclosed its unaudited interim results for 2026. In the first half of the year, the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1616","BK1587","02097","BK1233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143245213","title":"Zhaoke Ophthalmology's Half-Year Results: Net Loss Widens to RMB 123 Million Amid Rising Costs","url":"https://stock-news.laohu8.com/highlight/detail?id=1143245213","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143245213?lang=en_us&edition=fundamental","pubTime":"2026-08-28 22:53","pubTimestamp":1787928836,"startTime":"0","endTime":"0","summary":"Zhaoke Ophthalmology-B (06622) has released its interim results for the 2026 fiscal year, showing total revenue of RMB 18.828 million, a year-on-year increase of 19.14%. However, the company recorded...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1191","BK1574","06622","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662918410","title":"Ling Yue Services H1 FY26 Net Profit Drops 35.3% to RMB 34.3 Million; Revenue Falls 8% to RMB 295.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662918410","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662918410?lang=en_us&edition=fundamental","pubTime":"2026-08-28 22:31","pubTimestamp":1787927514,"startTime":"0","endTime":"0","summary":"Ling Yue Services H1 FY26 net profit drops 35.3% to RMB 34.3 million; revenue falls 8% to RMB 295.4 millionLing Yue Services Group posted net profit of RMB 34.3 million, down 35.3% year over year; bas","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL52y2th:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02165","BK1258","BK1542","BK1229","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662099200","title":"China's Ocumension Therapeutics H1 Revenue Surges on Higher Ophthalmic Product Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2662099200","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662099200?lang=en_us&edition=fundamental","pubTime":"2026-08-28 22:24","pubTimestamp":1787927067,"startTime":"0","endTime":"0","summary":"China's Ocumension Therapeutics H1 revenue surges on higher ophthalmic product salesOverviewChina ophthalmic pharma firm's half-year revenue rose 44.1% yr/yr to RMB423.7 mlnAdjusted net loss narrowed ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL1N44P0NI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1209","BK1587","BK1574","06622","01477","BK1583","02219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662290099","title":"InnoScience Appoints Wei Yu CFO, Replacing Zhong Shan","url":"https://stock-news.laohu8.com/highlight/detail?id=2662290099","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662290099?lang=en_us&edition=fundamental","pubTime":"2026-08-28 22:22","pubTimestamp":1787926959,"startTime":"0","endTime":"0","summary":"InnoScience appoints Wei Yu CFO, replacing Zhong ShanInnoscience appointed Wei Yu as chief financial officer for a three-year term starting Aug. 28, 2026.Yu joined the group in May 2026; previously le","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDLLk8PL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000320223.HKD","LU0051755006.USD","SG9999000459.SGD","LU2348773727.SGD","LU0261950470.USD","LU0048580855.USD","LU0052750758.USD","LU1974910355.USD","LU2106854487.HKD","LU0516422366.SGD","LU0211977185.USD","LU0588546209.SGD","LU1917777945.USD","LU0594300419.USD","LU0650527681.SGD","LU0011963245.USD","LU0384037296.USD","BK1604","LU0868486357.SGD","LU0516423091.SGD","BK1587","LU1282649067.USD","LU0329678170.USD","LU1719994722.HKD","LU2476274308.USD","LU2153591404.USD","LU0463099449.HKD","LU0708995583.HKD","LU1880383366.USD","SG9999002463.SGD","HK0000306701.USD","LU0048575426.USD","LU1224709979.USD","LU0149721374.USD","SG9999011746.SGD","09961","LU0488056044.USD","IE0003851619.USD","LU0823426308.USD","02577","LU0634319403.HKD","BK1163","LU1102505929.USD","LU0173614495.USD","LU0231483743.USD","LU1481107354.HKD","LU1282649810.SGD","LU0737861699.HKD","LU1808992512.USD","LU0261950983.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662099494","title":"Global New Material Swings to FY26 H1 Net Loss of RMB 93.36 Million; Revenue More than Doubled to RMB 2.56 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2662099494","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662099494?lang=en_us&edition=fundamental","pubTime":"2026-08-28 22:20","pubTimestamp":1787926849,"startTime":"0","endTime":"0","summary":"Global New Material swings to FY26 H1 net loss of RMB 93.36 million; revenue more than doubled to RMB 2.56 billionGlobal New Material International posted an IFRS net loss of RMB 93.36 million, swinging from profit in the year-ago period.Revenue more than doubled to RMB 2.56 billion, while gross profit rose 106.3% to RMB 977.74 million.Non-IFRS adjusted EBITDA increased 36.6% to RMB 589.26 million, while adjusted net profit fell 83.3% to RMB 43.47 million.Finance costs climbed to RMB 293.54 million; fair value loss on the derivative component of convertible bonds totaled RMB 110 million.Chairman flagged 1H 2026 as the first full half-year after the Merck Surface Solutions deal, with integration spanning clients, supply chain and R&D.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interprete","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL5KJBYh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1129","LU0274383008.USD","06616","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662994950","title":"Property Manager Landsea Green Life's H1 Revenue Falls on Exits from Loss-Making Projects","url":"https://stock-news.laohu8.com/highlight/detail?id=2662994950","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662994950?lang=en_us&edition=fundamental","pubTime":"2026-08-28 22:20","pubTimestamp":1787926844,"startTime":"0","endTime":"0","summary":"Property manager Landsea Green Life's H1 revenue falls on exits from loss-making projectsOverviewChina property manager's H1 2026 revenue fell 8% yr/yr to RMB358 mlnGross profit dropped 28.8% and marg","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL1N44P0MD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1258","BK1587","BK1542","06958","BK1229","01965","01502"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":13,"pageCount":12,"totalSize":259,"code":"91000000","status":"200"}]}}